Precise near patient solutions

Designed for healthcare professionals

About Us

DROPHIL BIOTECH, a high-tech research development and manufacturing company located in Shenzhen Pingshan National Biomedical Innovations Industrial Center. We dedicated to providing customised POCT solutions for health care professionals. Our innovative near patient solutions applicable for Emergency Dept, ICU, Chest pain centers and other clinical depts. Our patented AI powered morphological POCT total solutions perfectly serves various applications for Pet Clinics globally.

Products

Chemiluminescence Immunoassay Series

Auto Chemiluminescence Immunoassay Analyzer

Instrument Model: S200

Lyophilized micro-beads, no cold chain required

Single-dose, triple test cartridge

Dual chambers for simultaneous STAT assays of varying protocols

>
Chemiluminescence Immunoassay Series

Auto Chemiluminescence Immunoassay

Instrument Model: S400

Lyophilized micro-beads, no cold chain required

Single-dose, triple test cartridge

Independent chambers, enabling simultaneous STAT assays of varying protocols

>
Chemiluminescence Immunoassay Series

Auto Chemiluminescence Immunoassay Analyzer

Instrument Model: Auto 1000

Lyophilized micro-beads, no cold chain required

Single-dose, triple test cartridge

Real-time HCT correction

Independent chambers, enabling simultaneous STAT assays of varying protocols

Automatic sample loading

>

Solution

Covering a wide range of in vitro diagnostic (IVD) products from routine testing to special disease screening, ensuring accurate diagnosis for different diseases, and safeguard your health.

News

Good news: Congratulations to Drophil Biotech on winning the qualification of "Shenzhen Key Innovative Enterprise Introduction"

Recently, Shenzhen Science and Technology Innovation Bureau released the list of the first batch of enterprises awarded the qualification of "Shenzhen Key Innovative Enterprises Introduced" in 2024, and after a strict expert review process, Drophil Biotech (Shenzhen) Co., LTD. (referred to as Drophil Biotech) was successfully selected. It is reported that in June 2022, the Shenzhen Municipal
Company Dynamics